Silvercrest Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-29,350
Closed -$2.91M 780
2019
Q3
$2.91M Sell
29,350
-2,450
-8% -$233K 0.02% 423
2019
Q2
$2.94M Sell
31,800
-11,190
-26% -$1.06M 0.03% 286
2019
Q1
$4.06M Sell
42,990
-2,977
-6% -$260K 0.04% 254
2018
Q4
$2.95M Sell
45,967
-11,273
-20% -$832K 0.03% 268
2018
Q3
$5.12M Buy
57,240
+7,585
+15% +$670K 0.05% 223
2018
Q2
$3.94M Buy
49,655
+4,007
+9% +$333K 0.04% 264
2018
Q1
$4.07M Sell
45,648
-1,622
-3% -$156K 0.04% 248
2017
Q4
$4.93M Buy
47,270
+6,286
+15% +$709K 0.05% 233
2017
Q3
$5.98M Sell
40,984
-19
-0% -$2.59K 0.06% 211
2017
Q2
$5.33M Sell
41,003
-1,662
-4% -$204K 0.06% 218
2017
Q1
$5.31M Sell
42,665
-1,435
-3% -$172K 0.06% 218
2016
Q4
$5.11M Buy
44,100
+4,340
+11% +$483K 0.06% 215
2016
Q3
$4.16M Sell
39,760
-2,350
-6% -$254K 0.05% 236
2016
Q2
$4.15M Buy
42,110
+219
+0.5% +$22.7K 0.05% 234
2016
Q1
$4.19M Sell
41,891
-3,050
-7% -$314K 0.06% 218
2015
Q4
$5.38M Buy
44,941
+35,160
+359% +$4.07M 0.07% 207
2015
Q3
$1.06M Sell
9,781
-33,850
-78% -$4.2M 0.02% 323
2015
Q2
$5.05M Buy
43,631
+35,880
+463% +$4.1M 0.07% 216
2015
Q1
$894K Sell
7,751
-1,540
-17% -$184K 0.01% 328
2014
Q4
$1.04M Buy
9,291
+2,450
+36% +$258K 0.02% 314
2014
Q3
$648K Sell
6,841
-1,925
-22% -$174K 0.01% 339
2014
Q2
$753K Buy
8,766
+1,050
+14% +$79.8K 0.01% 334
2014
Q1
$539K Sell
7,716
-940
-11% -$74.4K 0.01% 340
2013
Q4
$731K Hold
8,656
0.01% 323
2013
Q3
$667K Sell
8,656
-6
-0.1% -$420 0.01% 325
2013
Q2
$507K Buy
+8,662
New +$521K 0.01% 327

Other funds holding CELG

Silvercrest Asset Management's CELG Position: Q4 2019 in Review

Silvercrest Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 29,350 shares — an estimated $2.91M sold.

Silvercrest Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.98M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Silvercrest Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Silvercrest Asset Management sold 29,350 Celgene Corp shares in Q4 2019, an estimated $2.91M.
  • Silvercrest Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Silvercrest Asset Management's Celgene Corp position peaked at $5.98M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Silvercrest Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.